BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.17.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T100000
DTEND;TZID=America/Vancouver:20211020T110000
DTSTAMP:20211004T165959Z
CREATED:20211004T165959Z
LAST-MODIFIED:20211004T165959Z
UID:18635-1634724000-1634727600@scienceinvancouver.com
SUMMARY:From Discovery to Market: The Role of IP Strategy in Drug Development
DESCRIPTION:Drug development in Canada is a long and complex process\, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value\, generating revenue\, and obtaining market intelligence. Without a strategy\, companies risk losing IP assets\, missing out on investment opportunities\, and being exposed to competition. \nOn Wednesday\, October 20\, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis\, international filing strategies and portfolio management\, and of course\, the unique industry challenges brought to light due to the COVID-19 pandemic. \n\n\n\n\n\n\nSpeakers:  \n\nBrian Kingwell\, Partner\, Gowling WLG\nIsabelle Riedl\, Senior Supervisor\, Intellectual Property\, Medicago\nSonia Ziesche\, Principal\, Patent Agent\, Gowling WLG\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Details:\n\n\n\n\n\n\n\n\n\n\n\nDate: Wednesday\, October 20\, 2021 \nTime: 10:00AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/from-discovery-to-market-the-role-of-ip-strategy-in-drug-development/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Gowling-Event-Images-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T100000
DTEND;TZID=America/Vancouver:20211020T110000
DTSTAMP:20211004T165959Z
CREATED:20211004T165959Z
LAST-MODIFIED:20211004T165959Z
UID:26444-1634724000-1634727600@scienceinvancouver.com
SUMMARY:From Discovery to Market: The Role of IP Strategy in Drug Development
DESCRIPTION:Drug development in Canada is a long and complex process\, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value\, generating revenue\, and obtaining market intelligence. Without a strategy\, companies risk losing IP assets\, missing out on investment opportunities\, and being exposed to competition. \nOn Wednesday\, October 20\, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis\, international filing strategies and portfolio management\, and of course\, the unique industry challenges brought to light due to the COVID-19 pandemic. \n\n\n\n\n\n\nSpeakers:  \n\nBrian Kingwell\, Partner\, Gowling WLG\nIsabelle Riedl\, Senior Supervisor\, Intellectual Property\, Medicago\nSonia Ziesche\, Principal\, Patent Agent\, Gowling WLG\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Details:\n\n\n\n\n\n\n\n\n\n\n\nDate: Wednesday\, October 20\, 2021 \nTime: 10:00AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/from-discovery-to-market-the-role-of-ip-strategy-in-drug-development-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Gowling-Event-Images-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T100000
DTEND;TZID=America/Vancouver:20211020T110000
DTSTAMP:20211004T165959Z
CREATED:20211004T165959Z
LAST-MODIFIED:20211004T165959Z
UID:28059-1634724000-1634727600@scienceinvancouver.com
SUMMARY:From Discovery to Market: The Role of IP Strategy in Drug Development
DESCRIPTION:Drug development in Canada is a long and complex process\, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value\, generating revenue\, and obtaining market intelligence. Without a strategy\, companies risk losing IP assets\, missing out on investment opportunities\, and being exposed to competition. \nOn Wednesday\, October 20\, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis\, international filing strategies and portfolio management\, and of course\, the unique industry challenges brought to light due to the COVID-19 pandemic. \n\n\n\n\n\n\nSpeakers:  \n\nBrian Kingwell\, Partner\, Gowling WLG\nIsabelle Riedl\, Senior Supervisor\, Intellectual Property\, Medicago\nSonia Ziesche\, Principal\, Patent Agent\, Gowling WLG\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Details:\n\n\n\n\n\n\n\n\n\n\n\nDate: Wednesday\, October 20\, 2021 \nTime: 10:00AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/from-discovery-to-market-the-role-of-ip-strategy-in-drug-development-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Gowling-Event-Images-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T100000
DTEND;TZID=America/Vancouver:20211020T110000
DTSTAMP:20211004T165959Z
CREATED:20211004T165959Z
LAST-MODIFIED:20211004T165959Z
UID:31142-1634724000-1634727600@scienceinvancouver.com
SUMMARY:From Discovery to Market: The Role of IP Strategy in Drug Development
DESCRIPTION:Drug development in Canada is a long and complex process\, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value\, generating revenue\, and obtaining market intelligence. Without a strategy\, companies risk losing IP assets\, missing out on investment opportunities\, and being exposed to competition. \nOn Wednesday\, October 20\, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis\, international filing strategies and portfolio management\, and of course\, the unique industry challenges brought to light due to the COVID-19 pandemic. \n\n\n\n\n\n\nSpeakers:  \n\nBrian Kingwell\, Partner\, Gowling WLG\nIsabelle Riedl\, Senior Supervisor\, Intellectual Property\, Medicago\nSonia Ziesche\, Principal\, Patent Agent\, Gowling WLG\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Details:\n\n\n\n\n\n\n\n\n\n\n\nDate: Wednesday\, October 20\, 2021 \nTime: 10:00AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/from-discovery-to-market-the-role-of-ip-strategy-in-drug-development-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Gowling-Event-Images-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T100000
DTEND;TZID=America/Vancouver:20211020T110000
DTSTAMP:20211004T165959Z
CREATED:20211004T165959Z
LAST-MODIFIED:20211004T165959Z
UID:32602-1634724000-1634727600@scienceinvancouver.com
SUMMARY:From Discovery to Market: The Role of IP Strategy in Drug Development
DESCRIPTION:Drug development in Canada is a long and complex process\, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value\, generating revenue\, and obtaining market intelligence. Without a strategy\, companies risk losing IP assets\, missing out on investment opportunities\, and being exposed to competition. \nOn Wednesday\, October 20\, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis\, international filing strategies and portfolio management\, and of course\, the unique industry challenges brought to light due to the COVID-19 pandemic. \n\n\n\n\n\n\nSpeakers:  \n\nBrian Kingwell\, Partner\, Gowling WLG\nIsabelle Riedl\, Senior Supervisor\, Intellectual Property\, Medicago\nSonia Ziesche\, Principal\, Patent Agent\, Gowling WLG\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Details:\n\n\n\n\n\n\n\n\n\n\n\nDate: Wednesday\, October 20\, 2021 \nTime: 10:00AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/from-discovery-to-market-the-role-of-ip-strategy-in-drug-development-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Gowling-Event-Images-1.png
END:VEVENT
END:VCALENDAR